- Home
- TRVI vs STGW Comparison
TRVI vs STGW Comparison
Compare TRVI & STGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRVI | STGW |
|---|---|---|
| Founded | 2011 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | TRVI | STGW |
|---|---|---|
| Price | $10.85 | $4.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $20.38 | $8.46 |
| AVG Volume (30 Days) | ★ 1.9M | 1.3M |
| Earning Date | 11-13-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1954.71 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $2,890,264,000.00 |
| Revenue This Year | N/A | $4.67 |
| Revenue Next Year | N/A | $8.98 |
| P/E Ratio | ★ N/A | $86.18 |
| Revenue Growth | N/A | ★ 6.75 |
| 52 Week Low | $3.47 | $4.03 |
| 52 Week High | $14.39 | $7.48 |
Technical Indicators
Market Signals| Indicator | TRVI | STGW |
|---|---|---|
| Relative Strength Index (RSI) | 33.45 | 42.83 |
| Support Level | $12.60 | $4.68 |
| Resistance Level | $13.16 | $5.05 |
| Average True Range (ATR) | 0.65 | 0.15 |
| MACD | -0.26 | -0.05 |
| Stochastic Oscillator | 9.28 | 30.60 |
Price Performance
Historical ComparisonAbout TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About STGW Stagwell Inc.
Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.